BROAD PORTFOLIO THROUGH BROAD EXPERTISE

RD&C combines diverse academic and scientific background with broad expertise and long experience in pharmaceutical industry and offers a highly specified and exceptional portfolio to its clients.

Impurities and degradation products – from identification to justification

 

Drug development process – from target validation to clinical phase

 

Pharmaceutical development – smart formulations for challenging APIs

 

Regulatory support – from IND to CTD

 

Environmental Risk Assessments – a new approach to prepare ERAs

 

In silico toxicology assessment – from impurity profiling to ERA

 

Commercial evaluation of drug development projects – from idea to market

 

Quality Management Support – from control to audit

 

Evaluation of production processes – from QbD to OOS events

 

Support for CRO selection – from request to match

 

Statistics – an inevitable tool in drug development

 

IP management – from claims to product portfolio

 

RD&C network – from academia to industry

 

Publication & scientific talks – RD&C’s scientific activities